Histamine dihydrochloride
Ceplene (histamine dihydrochloride) is a small molecule pharmaceutical. Histamine dihydrochloride was first approved as Ceplene on 2008-10-07. It is used to treat allergic rhinitis seasonal and urticaria in the USA. It has been approved in Europe to treat myeloid leukemia acute.
| Trade Name | Ceplene |
|---|---|
| Common Name | Histamine dihydrochloride |
| Indication | allergic rhinitis seasonal, myeloid leukemia acute, urticaria |
| Drug Class |
